SaNOtize Research and Development Corp

11:30 AM - 11:45 AM, Tuesday, June 4,2019 ・ SuS - Hall E, Booth 3971, Level 200
Therapeutics company focused on utilizing nitric oxide to treat topical infections and multifactorial diseases, particularly diseases caused by drug resistant microbes, through its patented releasing solution. This topical treatment addresses unmet needs of patients suffering from dermal and respiratory diseases, many of which have no effective treatment, negative side effects, or antimicrobial resistance due to the chronic overuse of antibiotics and other antimicrobial drugs across medical fields. The use of nitric oxide as an alternative therapy method could address the aforementioned problems because it is a naturally occurring nanomolecule in the body that has antibacterial, antiviral, and antifungal effects.
Speaker
photo
CEO
SaNOtize